CEO says move enhances company’s broader growth strategyMARYSVILLE, Ohio, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today expressed support for President Trump’s executive order to reschedule cannabis from a Schedule I to Schedule III drug. “With 39 states already legalizing cannabis in some form, rescheduling to a lower level drug on the federal level has been long overdue,” said Chairman ...

Trump Administration's Rescheduling Opens New Avenues for Research, Medical Advancement, and Investment This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-lookin ...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs†or the "Company†), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump's action to reschedule cannabis from a Schedule I to Schedule III substance under the Controlled Substances Act. "Today marks the most consequential moment in the history of U.S. cannabis. The decision to move cannabis from Schedule I to Schedule III will be a cultural turning point, ackn. ...

Verano’s active operations span 13 states, comprised of 158 dispensaries operating under the Zen Leaf™ and MÜV™ retail banners, and 15 cultivation and processing facilities with more than 1.1 million square feet of cultivation capacity CHICAGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, celebrates today’s historic announcement that President Donald Trump has issued an Executive Order directing the ...

Core Insights - Green Thumb Industries experienced a rally due to renewed optimism regarding cannabis rescheduling from the Trump administration, as reported in a Washington Post article [1] Industry Summary - The news has positively impacted US multi-state operators (MSOs) and Canadian cannabis licensed producers (LPs), indicating a potential shift in the regulatory landscape for the cannabis sector [1]

Fast money trader Tim Seymour. He's behind of course the Amplify Seymour cannabis ETF which surged nearly 55% today. Its best day on record.Such a good day that Tim comes to us in a hoodie. Tim >> in a hoodie. We're talking.Why wouldn't we. Why would I mean the rescheduling that has been something that investors are hoping for. It seems like you get a whiff of it, the stocks go up.You say this is for real this time. Why >> a whiff. No, no pun intended.So I I think it is real. I think it's always been real. ...

Core Insights - InterCure has entered into a definitive Share Purchase Agreement and a Collaboration Agreement with Cannasoul R&D Ltd, acquiring a 28% ownership stake in Cannasoul with an option to increase to 51% within two years [1][2] - The collaboration aims to combine InterCure's pharmaceutical platform with Cannasoul's research capabilities to develop evidence-based cannabis therapeutics [1][4] - The agreements come at a pivotal moment for the U.S. cannabis market, as the Trump administration is reportedly considering rescheduling cannabis, which could create significant opportunities for international cannabis companies like InterCure [2][4] Company Overview - InterCure Ltd. operates as Canndoc and is Israel's largest licensed cannabis producer, known for its pharmaceutical-grade medical cannabis products [5] - The company utilizes a vertically integrated "seed-to-sale" model and has a strong distribution network, positioning itself as a leader in the global cannabis market outside North America [5] Research and Development - Prof. Dedi Meiri, a prominent cannabis researcher, is expected to chair InterCure's newly established Scientific Advisory Board, enhancing the integration of Cannasoul's analytics into InterCure's operations [3][4] - The partnership aims to accelerate the development of next-generation cannabis therapeutics, leveraging Cannasoul's advanced research capabilities [3][4] Market Context - The potential rescheduling of cannabis from Schedule I to Schedule III by the Trump administration could transform the regulatory landscape, unlocking new opportunities for companies like InterCure [2][4]

Group 1 - Innovative Industrial Properties (NYSE: IIPR) is experiencing volatility due to tenant defaults and challenges faced by cannabis operators from competition and illicit markets [1] - The company is focused on identifying undervalued firms with strong growth potential and solid management teams [1] - The investment strategy combines growth-oriented principles with strict valuation criteria to enhance safety margins [1] Group 2 - The cannabis industry is under pressure from both legal competition and illegal operators, impacting the performance of companies like IIPR [1] - The investment group led by Julian Lin emphasizes high-conviction stock picks that are likely to outperform the S&P 500 [1]

Industry Overview - Investors in marijuana stocks are anticipating news regarding cannabis rescheduling, which historically leads to an increase in stock prices for cannabis companies [1][2] - The cannabis sector has faced challenges but is now showing signs of growth and potential legalization, which could significantly impact stock performance [2][3] Company Highlights - **GrowGeneration Corp.** operates retail stores focused on hydroponic and organic gardening products in the U.S. and has announced participation in the H.C. Wainwright 27th Annual Global Investment Conference [4][6] - **Hydrofarm Holdings Group, Inc.** manufactures and distributes hydroponics equipment in the U.S. and Canada, with its latest financial update released in August 2023 [7][8] - **The Scotts Miracle-Gro Company** engages in the manufacture and sale of gardening products and has recently published its 2025 Corporate Responsibility report, outlining its sustainability goals [10][12] Financial Performance - The Scotts Miracle-Gro Company reported a decrease in net sales to $39.2 million from $54.8 million, with a gross profit margin decline to 7.1% from 19.8% [13] - Adjusted gross profit margin also decreased to 19.2% from 24.4%, while net loss improved to $16.9 million from $23.5 million [13] - The company initiated a restructuring plan aimed at reducing costs and improving operational efficiency [13]

Industry Overview - The cannabis industry is experiencing significant growth, particularly in the USA, Canada, and Europe, with increasing demand for cannabis products [1][2] - The legal cannabis sector has surpassed a valuation of over a billion dollars, and despite recent declines, it is expected to rise again soon due to ongoing federal reform efforts [2][3] Market Performance - There has been a slight turnaround in trading, with more consistent upward trends observed, indicating potential for a market bounce [3] - Shareholders are closely monitoring the sector for upcoming changes, particularly related to cannabis re-scheduling in the USA [3] Company Highlights - **Greenlane Holdings, Inc.** focuses on the development and distribution of cannabis accessories and lifestyle products across multiple regions [4] - **GrowGeneration Corp.** operates retail hydroponic and organic gardening stores in the USA, with a recent strategic partnership with Arett Sales to expand its wholesale and B2B strategy [8][11] Financial Results - Greenlane Holdings reported Q2 2025 total revenue of $0.8 million, down from $2.6 million in the prior year, with operating expenses reduced by 27% to $3.3 million [9] - GrowGeneration's operating loss improved to $3.3 million compared to $3.5 million in the prior year, while net loss increased to $3.2 million from $0.6 million [9]